Morocco As a Possible Source for Acquisition of Rhinocladiella Mackenziei

Overview

Journal PLoS Negl Trop Dis

Specialties Infectious Diseases
Tropical Medicine

Date 2021 Aug 19

PMID 34411105

Citations 3

Authors

Baptiste Lafont Rapnouil

Jeremie F Cohen

Eric Bailly

Louis Bernard

Dea Garcia-Hermoso

Fanny Lanternier

Catherine Horodyckid

Lucie Limousin

Ephrem Salame

Ilyess Zemmoura

Guillaume Desoubeaux

Olivier Lortholary

Affiliations

Soon will be listed here.

Abstract

Rhinocladiella mackenziei cerebral phaeohyphomycosis is a rare severe disease that has been typically described in the Middle East. Here, we report 2 cases of R. mackenziei cerebral phaeohyphomycosis in patients from Morocco, diagnosed and treated in France, and raise a concern about the ever-going extension of the area at risk for this devastating invasive fungal infection.

Citing Articles

cerebral phaeohyphomycosis with a definitive outcome.

Aldraihem M, AlDosary O, Almasaud W, Alqurashi R, Abu-Amara A BMJ Case Rep. 2023; 16(5).

PMID: 37221005 PMC: 10230860. DOI: 10.1136/bcr-2022-250787.

Cerebral phaeohyphomycosis at a tertiary healthcare center in Saudi Arabia.

Alabdely M, Alolayan A, Almaghrabi R, Al-Abdely H Neurosciences (Riyadh). 2023; 28(2):136-142.

PMID: 37045456 PMC: 10155477. DOI: 10.17712/nsj.2023.2.20220118.

Domain Fusion of Two Oxygenases Affords Organophosphonate Degradation in Pathogenic Fungi.

Langton M, Appell M, Koob J, Pandelia M Biochemistry. 2022; 61(11):956-962.

PMID: 35506879 PMC: 9177745. DOI: 10.1021/acs.biochem.2c00163.

References

Badali H, Chander J, Bansal S, Aher A, Borkar S, Meis J . First autochthonous case of Rhinocladiella mackenziei cerebral abscess outside the Middle East. J Clin Microbiol. 2009; 48(2):646-9. PMC: 2815588. DOI: 10.1128/JCM.01855-09. View

Hardman N, Young N, Hobson R, Sandoe J, Wellberry-Smith M, Thomson S . Prolonged survival after disseminated Rhinocladiella infection treated with surgical excision and posaconazole. Transpl Infect Dis. 2020; 22(2):e13264. DOI: 10.1111/tid.13264. View

Moreno L, Ahmed A, Brankovics B, Cuomo C, Menken S, Taj-Aldeen S . Genomic Understanding of an Infectious Brain Disease from the Desert. G3 (Bethesda). 2018; 8(3):909-922. PMC: 5844311. DOI: 10.1534/g3.117.300421. View

Cristini A, Garcia-Hermoso D, Celard M, Albrand G, Lortholary O . Cerebral phaeohyphomycosis caused by Rhinocladiella mackenziei in a woman native to Afghanistan. J Clin Microbiol. 2010; 48(9):3451-4. PMC: 2937739. DOI: 10.1128/JCM.00924-10. View

Jabeen K, Farooqi J, Zafar A, Jamil B, Mahmood S, Ali F . Rhinocladiella mackenziei as an emerging cause of cerebral phaeohyphomycosis in Pakistan: a case series. Clin Infect Dis. 2011; 52(2):213-7. DOI: 10.1093/cid/ciq114. View

Garcia-Hermoso D, Hamane S, Fekkar A, Jabet A, Denis B, Siguier M . Invasive Infections with Nannizziopsis obscura Species Complex in 9 Patients from West Africa, France, 2004-2020. Emerg Infect Dis. 2020; 26(9). PMC: 7454062. DOI: 10.3201/eid2609.200276. View

Al-Abdely H, Alkhunaizi A, Al-Tawfiq J, Hassounah M, Rinaldi M, Sutton D . Successful therapy of cerebral phaeohyphomycosis due to Ramichloridium mackenziei with the new triazole posaconazole. Med Mycol. 2005; 43(1):91-5. DOI: 10.1080/13693780400011104. View

Mohammadi R, Mohammadi A, Ashtari F, Khorvash F, Hakamifard A, Vaezi A . Cerebral phaeohyphomycosis due to Rhinocladiella mackenziei in Persian Gulf region: A case and review. Mycoses. 2017; 61(4):261-265. DOI: 10.1111/myc.12734. View

Barde F, Billaud E, Goldwirt L, Horodyckid C, Jullien V, Lanternier F . Low Central Nervous System Posaconazole Concentrations during Cerebral Phaeohyphomycosis. Antimicrob Agents Chemother. 2019; 63(11). PMC: 6811437. DOI: 10.1128/AAC.01184-19. View

10.

Badali H, de Hoog G, Curfs-Breuker I, Meis J . In vitro activities of antifungal drugs against Rhinocladiella mackenziei, an agent of fatal brain infection. J Antimicrob Chemother. 2009; 65(1):175-7. DOI: 10.1093/jac/dkp390. View

11.

Revankar S, Sutton D, Rinaldi M . Primary central nervous system phaeohyphomycosis: a review of 101 cases. Clin Infect Dis. 2003; 38(2):206-16. DOI: 10.1086/380635. View

12.

Yusupov N, Merve A, Warrell C, Johnson E, Curtis C, Samandouras G . Multiple brain abscesses caused by Rhinocladiella mackenziei in an immunocompetent patient: a case report and literature review. Acta Neurochir (Wien). 2017; 159(9):1757-1763. DOI: 10.1007/s00701-017-3141-0. View

13.

Badali H, Prenafeta-Boldu F, Guarro J, Klaassen C, Meis J, de Hoog G . Cladophialophora psammophila, a novel species of Chaetothyriales with a potential use in the bioremediation of volatile aromatic hydrocarbons. Fungal Biol. 2011; 115(10):1019-29. DOI: 10.1016/j.funbio.2011.04.005. View

14.

Garcia-Hermoso D, Hoinard D, Gantier J, Grenouillet F, Dromer F, Dannaoui E . Molecular and phenotypic evaluation of Lichtheimia corymbifera (formerly Absidia corymbifera) complex isolates associated with human mucormycosis: rehabilitation of L. ramosa. J Clin Microbiol. 2009; 47(12):3862-70. PMC: 2786664. DOI: 10.1128/JCM.02094-08. View

15.

Arzanlou M, Groenewald J, Gams W, Braun U, Shin H, Crous P . Phylogenetic and morphotaxonomic revision of Ramichloridium and allied genera. Stud Mycol. 2008; 58:57-93. PMC: 2104745. DOI: 10.3114/sim.2007.58.03. View

16.

Badali H, Bonifaz A, Barron-Tapia T, Vazquez-Gonzalez D, Estrada-Aguilar L, Oliveira N . Rhinocladiella aquaspersa, proven agent of verrucous skin infection and a novel type of chromoblastomycosis. Med Mycol. 2010; 48(5):696-703. DOI: 10.3109/13693780903471073. View

17.

Al-Abdely H, Najvar L, Bocanegra R, Fothergill A, Loebenberg D, Rinaldi M . SCH 56592, amphotericin B, or itraconazole therapy of experimental murine cerebral phaeohyphomycosis due to Ramichloridium obovoideum ("Ramichloridium mackenziei"). Antimicrob Agents Chemother. 2000; 44(5):1159-62. PMC: 89838. DOI: 10.1128/AAC.44.5.1159-1162.2000. View

18.

Revankar S, Sutton D . Melanized fungi in human disease. Clin Microbiol Rev. 2010; 23(4):884-928. PMC: 2952981. DOI: 10.1128/CMR.00019-10. View